These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Hypertension in end-stage renal failure: role of sympathetic nervous system, sodium balance and renal pressor system. Zucchelli P; Zuccala A; Sturani A; Degli Esposti E; Ligabue A; Santoro A; Gattiani A; Chiarini C Life Support Syst; 1983; 1(2):101-11. PubMed ID: 6381895 [TBL] [Abstract][Full Text] [Related]
27. [Determination of plasma gastrin in patients with chronic uremia undergoing hemodialytic treatment]. Splendiani G; D'Allessandro V; Acitelli S Minerva Nefrol; 1976; 23(5):343-6. PubMed ID: 1018869 [No Abstract] [Full Text] [Related]
28. [Physical exercise during hemodialysis session: effect on quality of life]. Rizzioli E; Cerretani D; Normanno M; Munaro D; Berto A; Contarello G; Rizzo E; Conz PA G Ital Nefrol; 2004; 21 Suppl 30():S236-40. PubMed ID: 15750992 [TBL] [Abstract][Full Text] [Related]
29. Response of peripheral plasma renin activity (PRA) to furosemide stimulation; reduction of the renal parenchyma as a limiting factor. Zabka J; Stríbrná J; Rotnáglová Z Physiol Bohemoslov; 1981; 30(5):397-403. PubMed ID: 6459589 [TBL] [Abstract][Full Text] [Related]
30. [Criteria for the selection of dialytic treatment in uremia]. Monasterio G Minerva Nefrol; 1969; 16(5):333-4. PubMed ID: 5399506 [No Abstract] [Full Text] [Related]
31. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
32. [Hyperuricemia and plasma renin activity in essential arterial hypertension]. Milicević Z; Jelaković B; Marinković M Lijec Vjesn; 1994; 116(1-2):14-7. PubMed ID: 8028431 [TBL] [Abstract][Full Text] [Related]
33. The influence of hemodiafiltration on blood pressure regulation. Levy SB; Stone RA; Ford CA; Beans E; Henderson LW Trans Am Soc Artif Intern Organs; 1977; 23():691-3. PubMed ID: 910401 [No Abstract] [Full Text] [Related]
34. [Vasopressin and renin-aldosterone system in patients with arterial hypertension]. Kasenova SL Klin Med (Mosk); 2002; 80(12):31-4. PubMed ID: 12638408 [TBL] [Abstract][Full Text] [Related]
35. [Regular dialytic treatment in the Piedmont region. Results and prospects]. Quarello F; Bossi P; Pacitti A; Bosticardo GM; Belardi P; Roccatello D; Aprato A; Boero R; Basolo B; Berto M; Sancipriano GP; Piccoli G Arch Sci Med (Torino); 1981; 138(4):533-42. PubMed ID: 7340738 [TBL] [Abstract][Full Text] [Related]
36. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy]. Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066 [No Abstract] [Full Text] [Related]
37. [Hypothesis of the pathogenesis of renoparenchymal hypertension in chronic kidney failure patients before starting treatment with periodic hemodialysis]. Stefanov G Vutr Boles; 1984; 23(1):34-9. PubMed ID: 6730448 [TBL] [Abstract][Full Text] [Related]
38. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia]. Popławski A; Myśliwiec M Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935 [TBL] [Abstract][Full Text] [Related]
39. [The mechanisms of the development of arterial hypertension in patients with chronic kidney failure treated by hemodialysis]. Konstantinov IuV; Komandenko MS; Nikolaeva AA; D'iachuk MM Urol Nefrol (Mosk); 1993; (3):39-41. PubMed ID: 7941161 [TBL] [Abstract][Full Text] [Related]
40. [Influence of hemodialysis on the levels of zinc in chronic uremia]. De Sancho JL; Montenegro J; Ruíz De Gauna R; Gómez-Ullate P; García Damborenea R Rev Clin Esp; 1980 Feb; 156(3):179-81. PubMed ID: 7367711 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]